These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17869104)

  • 1. Discovery of potent T-type calcium channel blocker.
    Seo HN; Choi JY; Choe YJ; Kim Y; Rhim H; Lee SH; Kim J; Joo DJ; Lee JY
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5740-3. PubMed ID: 17869104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR study of T-type calcium channel blockers. Part II.
    Choe YJ; Seo HN; Jung SY; Rhim H; Kim J; Choo DJ; Lee JY
    Arch Pharm (Weinheim); 2008 Oct; 341(10):661-4. PubMed ID: 18816587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
    Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.
    Rhim H; Lee YS; Park SJ; Chung BY; Lee JY
    Bioorg Med Chem Lett; 2005 Jan; 15(2):283-6. PubMed ID: 15603940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).
    Jeong JA; Cho H; Jung SY; Kang HB; Park JY; Kim J; Choo DJ; Lee JY
    Bioorg Med Chem Lett; 2010 Jan; 20(1):38-41. PubMed ID: 19951839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
    Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel T-type calcium channel blockers.
    Choi JY; Seo HN; Lee MJ; Park SJ; Park SJ; Jeon JY; Kang JH; Pae AN; Rhim H; Lee JY
    Bioorg Med Chem Lett; 2007 Jan; 17(2):471-5. PubMed ID: 17064894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers.
    Lee YS; Lee BH; Park SJ; Kang SB; Rhim H; Park JY; Lee JH; Jeong SW; Lee JY
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3379-84. PubMed ID: 15177437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers.
    Ku IW; Cho S; Doddareddy MR; Jang MS; Keum G; Lee JH; Chung BY; Kim Y; Rhim H; Kang SB
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5244-8. PubMed ID: 16876404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into the structure-activity relationship of novel concentration dependent, dual action T-type calcium channel agonists/antagonists.
    McCalmont WF; Patterson JR; Lindenmuth MA; Heady TN; Haverstick DM; Gray LS; Macdonald TL
    Bioorg Med Chem; 2005 Jun; 13(11):3821-39. PubMed ID: 15863008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
    Doddareddy MR; Choo H; Cho YS; Rhim H; Koh HY; Lee JH; Jeong SW; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(2):1091-105. PubMed ID: 17074493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonists.
    Schlegel KA; Yang ZQ; Reger TS; Shu Y; Cube R; Rittle KE; Bondiskey P; Bock MG; Hartman GD; Tang C; Ballard J; Kuo Y; Prueksaritanont T; Nuss CE; Doran SM; Fox SV; Garson SL; Kraus RL; Li Y; Uebele VN; Renger JJ; Barrow JC
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5147-52. PubMed ID: 20673719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core.
    Hangeland JJ; Cheney DL; Friends TJ; Swartz S; Levesque PC; Rich AJ; Sun L; Bridal TR; Adam LP; Normandin DE; Murugesan N; Ewing WR
    Bioorg Med Chem Lett; 2008 Jan; 18(2):474-8. PubMed ID: 18160281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-type Ca2+ channel blockers suppress the growth of human cancer cells.
    Heo JH; Seo HN; Choe YJ; Kim S; Oh CR; Kim YD; Rhim H; Choo DJ; Kim J; Lee JY
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3899-901. PubMed ID: 18585035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.
    Lee HK; Lee YS; Roh EJ; Rhim H; Lee JY; Shin KJ
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4424-7. PubMed ID: 18625556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First pharmacophoric hypothesis for T-type calcium channel blockers.
    Doddareddy MR; Jung HK; Lee JY; Lee YS; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Apr; 12(7):1605-11. PubMed ID: 15028253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead discovery and optimization of T-type calcium channel blockers.
    Park JH; Choi JK; Lee E; Lee JK; Rhim H; Seo SH; Kim Y; Doddareddy MR; Pae AN; Kang J; Roh EJ
    Bioorg Med Chem; 2007 Feb; 15(3):1409-19. PubMed ID: 17150365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.